Six Independent Proof Points
Every material claim Sonotu makes about its technology has been validated by an independent third party — clinical, regulatory, algorithmic, and manufacturing.
01 · Institutional
University of Warwick Spin-Out, independently assessed and endorsed for commercial viability.
02 · Clinical
Green Pastures Hospital evaluated Gen1 under real clinical conditions in Pokhara, Nepal.
03 · Technical
ManCAD at the University of Manchester validated core signal processing performance against IEC and ANSI benchmarks.
04 · Manufacturing
Devices are manufactured by RVM in Chennai under ISO 13485:2016 medical device quality certification.
05 · Regulatory
Commercially launched and distributing nationally in India with certified Gen1 product foundations.
06 · Platform
HeartuAI™ and RULPS create a fundamentally different hearing architecture for emerging markets.
Register Your Interest
To receive the Investment Memorandum, self-certify as a qualifying investor. A member of the team will respond within two business days.